Press-release for stocks related to events for TAK

Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
Published: 2023-03-30 (Crawled : 11:00) - biospace.com/
TAK | News | $13.255 0.72% 200K

| -20.16% | O: -0.67% H: 0.89% C: -0.06%
meeting

Phase 2b Clinical Trial Results for TYK2 Inhibitor Presented at American Academy of Dermatology Annual Meeting
Published: 2023-03-20 (Crawled : 14:20) - biospace.com/
TAK | News | $13.255 0.72% 200K

| -19.77% | O: -0.73% H: 0.78% C: 0.61%
meeting trial

| -11.39% | O: 0.81% H: 1.04% C: 0.13%
blood

Oak Hill Bio to Participate in 2022 Wells Fargo Private Biotech Symposium
Published: 2022-05-27 (Crawled : 13:00) - biospace.com/
TAK | News | $13.255 0.72% 200K

| -11.74% | O: -0.94% H: 0.0% C: 0.0%
biotech symposium

Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting
Published: 2022-05-26 (Crawled : 11:00) - biospace.com/
TAK | News | $13.255 0.72% 200K

| -11.89% | O: -0.17% H: 0.0% C: 0.0%
NVS | $93.815 1.35% 410K

| 1.86% | O: -0.11% H: 0.0% C: 0.0%
XNCR | $18.65 -1.58% 130K

| -15.73% | O: -0.33% H: 0.0% C: 0.0%
MOR | $18.0 -0.28% 33K

| 250.49% | O: 3.5% H: 2.14% C: 0.19%
INCY | $52.45 -0.7% 530K

| -30.44% | O: 1.26% H: 0.95% C: -1.13%

Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting - Apr 01, 2022
Published: 2022-04-01 (Crawled : 09:00) - biospace.com/
MNTS | $0.3711 77K

| -87.77% | O: -0.31% H: 3.14% C: -0.94%
TAK | News | $13.255 0.72% 200K

| -8.17% | O: 0.56% H: 0.76% C: 0.76%

Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
Published: 2022-03-25 (Crawled : 14:20) - biospace.com/
TAK | News | $13.255 0.72% 200K

| -12.1% | O: -0.53% H: 0.57% C: 0.34%
JNJ | News | $146.39 0.45% 1.8M

| -16.95% | O: 0.65% H: 0.0% C: 0.0%
ARCT 4 | $26.305 -0.06% 65K

| -6.27% | O: 0.0% H: 0.0% C: -3.21%
rare therapeutics disease

| -3.13% | O: 1.55% H: 0.0% C: 0.0%
ema research